China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	19.40B
Revenue (ttm)	11.21B
Net Income (ttm)	1.63B
Shares Out	1.03B
EPS (ttm)	1.58
PE Ratio	11.93
Forward PE	11.18
Dividend	0.20 (1.06%)
Ex-Dividend Date	Nov 8, 2024

Volume	11,720,780
Average Volume	14,300,085
Open	19.47
Previous Close	19.48
Day's Range	19.30 - 19.54
52-Week Range	17.19 - 26.15
Beta	0.16
RSI	57.45
Earnings Date	Mar 20, 2025

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 12,269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, an increase of 9.68% compared to the previous year's 10.22 billion. Earnings were 1.63 billion, an increase of 22.11%.